Breast cancer bone metastases: pathogenesis and therapeutic targets

QR Code

Breast cancer bone metastases: pathogenesis and therapeutic targets

© 2018 Elsevier Ltd. Breast cancer is the most common cancer affecting women worldwide, with bone metastases presenting as the most common site of disease recurrence. Bone metastases secondary to breast cancer negatively impacts patient survival, mobility, and quality of life. Furthermore, the clini...

Full description

Bibliographic Details
Main Authors:	Brook, Naomi, Brook, Erin, Dharmarajan, Arunasalam, Dass, Crispin, Chan, Arlene
Format:	Journal Article
Published:	Pergamon 2018
Online Access:	http://hdl.handle.net/20.500.11937/65663

Similar Items

Pigment epithelium-derived factor and menopause in metastatic breast cancer
by: Brook, Naomi Louise
Published: (2022)

Bone drug targets
by: Dass, Crispin
Published: (2018)

Wnt signaling in triple-negative breast cancer
by: Pohl, S., et al.
Published: (2017)

Transdifferentiation of myoblasts into osteoblasts - possible use for bone therapy
by: Lin, Daphne, et al.
Published: (2017)

Mucinous adenocarcinoma of the rectum with breast and ocular metastases
by: Hisham, Raja B., et al.
Published: (2006)

Role of calpain in breast cancer and regulation of therapeutic response to targeted treatment
by: Pu, Xuan
Published: (2016)

Anterior uveal and episcleral metastases from carcinoma of the breast
by: Reddy, S.C., et al.
Published: (2000)

Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer
by: Green, Andrew R., et al.
Published: (2016)

Application of Proteomics Approaches in the Identification of New Markers and Therapeutic Targets for Breast Cancer
by: Moh’d Hamadneh, Lama Abdel Qader
Published: (2008)

Development of samarium-doped microspheres for internal radiotherapy treatment of bone metastases
by: Arjuna, Andi
Published: (2025)

p53-targeted cancer pharmacotherapy: move towards small molecule compounds
by: Kim, S., et al.
Published: (2011)

Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer
by: Ko, S., et al.
Published: (2014)

Small molecules which improve pathogenesis of myotonic dystrophy type 1
by: López-Morató, Marta, et al.
Published: (2018)

Alveolar rhabdomyosarcoma of the left hand with bilateral breast metastases in an adolescent female
by: Tan, Geok Chin, et al.
Published: (2008)

Metabolic stress and cancer: is autophagy the common denominator and a feasible target?
by: Giuliani, C., et al.
Published: (2014)

Understanding the pathogenesis and potential therapeutics of Myotonic dystrophy
by: Verma, Ayushri
Published: (2024)

Advances in psoriasis research: from pathogenesis to therapeutics
by: Sugumaran, Dineshwar, et al.
Published: (2024)

The Molecular Pathogenesis of Osteosarcoma: A Review
by: Choong, P., et al.
Published: (2011)

TILs in metastatic breast cancer—no surprises, but more questions
by: Chan, Arlene
Published: (2017)

Evaluation of Replication Protein A (RPA) as a prognostic and therapeutic target in breast and ovarian cancer
by: Algethami, Mashael
Published: (2024)

Molecular aspects of glucose homeostasis in skeletal muscle - A focus on the molecular mechanisms of insulin resistance.
by: Carnagarin, R., et al.
Published: (2015)

PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes
by: Carnagarin, R., et al.
Published: (2015)

PEDF-induced alteration of metabolism leading to insulin resistance
by: Carnagarin, Revathy, et al.
Published: (2015)

Capecitabine and vinorelbine in metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2009)

Targeted therapy for cancer using pH-responsive nanocarrier systems
by: Manchun, S., et al.
Published: (2012)

Cancer stem cell metabolism: A potential target for cancer therapy
by: Deshmukh, A., et al.
Published: (2016)

Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
by: Chan, Arlene
Published: (2017)

SFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease
by: Warrier, Sudha, et al.
Published: (2016)

Segmenting CT images of bronchogenic carcinoma with bone metastases using PET intensity markers approach
by: Avazpour, Iman, et al.
Published: (2009)

Neratinib in HER-2-positive breast cancer: Results to date and clinical usefulness
by: Chan, Arlene
Published: (2016)

Regulation of MT1-MMP and MMP-2 by the Serpin PEDF: A promising new target for metastatic cancer
by: Alcantara, M., et al.
Published: (2013)

Unveiling potential therapeutic targets for breast cancer recurrence: differentially expressed genes and pathways in post-surgery patients
by: Hamad, Hamad Ali, et al.
Published: (2024)

HER2 positive metastatic breast cancer: What happens after first line failure?
by: Chan, Arlene
Published: (2016)

Bone morphogenetic protein-2 and bone therapy: Successes and pitfalls
by: Poon, B., et al.
Published: (2016)

The potential role of free chitosan in bone trauma and bone cancer management
by: Tan, M., et al.
Published: (2014)

Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016)

Insulin antagonises pigment epithelium-derived factor (PEDF)-induced modulation of lineage commitment of myocytes and heterotrophic ossification
by: Carnagarin, R., et al.
Published: (2018)

Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy
by: Baxter-Holland, M., et al.
Published: (2018)

Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells
by: Perumal, Vanathi, et al.
Published: (2015)

Weak bones in diabetes mellitus - an update on pharmaceutical treatment options
by: Lin, D., et al.
Published: (2017)